Safe transient CAR-T platform for allergies
Explore AllerGene AI Therapeutics’ Safe transient CAR-T platform for allergies, designed to deliver targeted allergy treatment with enhanced safety and reduced long-term risks. Under the leadership of CEO Sidharth Kerka, the company is redefining advanced allergy therapeutics.
